Use of Low-level Laser Therapy (808nm) to Muscle Fatigue Resistance

NCT01972100 | Completed

• 1 other identifier: CEP/UFRN 401/09
• Study Type: interventional
• Target: 7
• Locations: 1 country
• Sites: 1

Brief Summary

The study hypothesis is a improved muscle fatigue resistance induced by low-level laser therapy applied between sets of intense exercises.

Conditions

Healthy

Keywords

Low-level laser therapy; Muscle fatigue resistance

Outcome Measures

Primary Outcomes (1)

• Maximum repetitions

  Evaluation of maximum repetitions of knee flexion-extension in isokinetic dynamometer. Volunteers were assessed on Monday (pre evaluation - baseline), on Wednesday performed a session of exercises and on Friday were assessed again (final evaluation).

  1 week

Secondary Outcomes (1)

• Median Frequency

  1 week

Study Arms (2)

Low-level laser therapy (LLLT)

ACTIVE COMPARATOR

Use of low-level laser therapy (LLLT) to induce a muscle fatigue resistance in intense exercises

Device: Low-level laser therapy (808nm); Other: isokinetic exercise

Placebo low-level laser therapy (Placebo)

ACTIVE COMPARATOR

Use of low-level laser therapy (LLLT) placebo to induce a muscle fatigue resistance

Other: isokinetic exercise; Device: Placebo low-level laser therapy

Interventions

Low-level laser therapy (808nm) DEVICE

Use of low-level laser therapy(LLLT)or placebo-LLLT applied on quadriceps femoris muscles between sets of isokinetic knee flexion-extension exercise

Also known as: Low-level laser therapy;, Placebo low-level laser theraphy, Laser device (808nm; 100mW; DMC®, Brazil).

Low-level laser therapy (LLLT)

isokinetic exercise OTHER

Also known as: Isokinetic knee flexion-extension exercise

Low-level laser therapy (LLLT); Placebo low-level laser therapy (Placebo)

Placebo low-level laser therapy DEVICE

Placebo low-level laser therapy (Placebo)

Eligibility Criteria

• Age: 18 Years - 28 Years
• Sex: male
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• healthy males
• physically active
• aged between 18-28 years old

You may not qualify if:

• smoker
• under medicine
• lower limb lesions limiting the flexion-extension of the knee joint

Sponsors & Collaborators

• Cleber Ferraresi: lead
• Universidade Federal do Rio Grande do Norte: collaborator

Study Sites (1)

Federal Univesity of Rio Grande do Norte

Rio Grande Do Norte, Natal, 59072-970, Brazil

Location

Related Publications (4)

• Felismino AS, Costa EC, Aoki MS, Ferraresi C, de Araujo Moura Lemos TM, de Brito Vieira WH. Effect of low-level laser therapy (808 nm) on markers of muscle damage: a randomized double-blind placebo-controlled trial. Lasers Med Sci. 2014 May;29(3):933-8. doi: 10.1007/s10103-013-1430-2. Epub 2013 Sep 5.

  PMID: 24005882 BACKGROUND

• Ferraresi C, Hamblin MR, Parizotto NA. Low-level laser (light) therapy (LLLT) on muscle tissue: performance, fatigue and repair benefited by the power of light. Photonics Lasers Med. 2012 Nov 1;1(4):267-286. doi: 10.1515/plm-2012-0032.

  PMID: 23626925 BACKGROUND

• Vieira WH, Ferraresi C, Perez SE, Baldissera V, Parizotto NA. Effects of low-level laser therapy (808 nm) on isokinetic muscle performance of young women submitted to endurance training: a randomized controlled clinical trial. Lasers Med Sci. 2012 Mar;27(2):497-504. doi: 10.1007/s10103-011-0984-0. Epub 2011 Aug 26.

  PMID: 21870127 BACKGROUND

• Ferraresi C, de Brito Oliveira T, de Oliveira Zafalon L, de Menezes Reiff RB, Baldissera V, de Andrade Perez SE, Matheucci Junior E, Parizotto NA. Effects of low level laser therapy (808 nm) on physical strength training in humans. Lasers Med Sci. 2011 May;26(3):349-58. doi: 10.1007/s10103-010-0855-0. Epub 2010 Nov 18.

  PMID: 21086010 BACKGROUND

MeSH Terms

Interventions

Low-Level Light Therapy; Lasers

Intervention Hierarchy (Ancestors)

Laser Therapy; Therapeutics; Phototherapy; Optical Devices; Equipment and Supplies; Radiation Equipment and Supplies

Study Officials

• Cleber Ferraresi, MD

  Universidade Federal de Sao Carlos

  PRINCIPAL INVESTIGATOR

• Wouber Hérickson de Brito Vieira, PhD

  Universidade Federal do Rio Grande do Norte

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Cleber Ferraresi

Study Record Dates

• First Submitted: October 22, 2013
• First Posted: October 30, 2013
• Study Start: April 1, 2013
• Primary Completion: September 1, 2013
• Study Completion: October 1, 2013
• Last Updated: October 30, 2013

Record last verified: 2013-10

Locations

BR (1)